These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients. Haerian BS, Lim KS, Tan HJ, Mohamed EH, Tan CT, Raymond AA, Wong CP, Wong SW, Omar H, Roslan H, Mohamed Z. Epileptic Disord; 2011 Mar; 13(1):65-75. PubMed ID: 21388909 [Abstract] [Full Text] [Related]
3. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Seo T, Ishitsu T, Ueda N, Nakada N, Yurube K, Ueda K, Nakagawa K. Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003 [Abstract] [Full Text] [Related]
4. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population. Lakhan R, Misra UK, Kalita J, Pradhan S, Gogtay NJ, Singh MK, Mittal B. Epilepsy Behav; 2009 Jan; 14(1):78-82. PubMed ID: 18812236 [Abstract] [Full Text] [Related]
5. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study. Ebid AH, Ahmed MM, Mohammed SA. Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887 [Abstract] [Full Text] [Related]
7. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Sills GJ, Mohanraj R, Butler E, McCrindle S, Collier L, Wilson EA, Brodie MJ. Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428 [Abstract] [Full Text] [Related]
8. Lack of association of ABCB1 haplotypes on five loci with response to treatment in epilepsy. Haerian BS, Lim KS, Mohamed EH, Tan HJ, Tan CT, Raymond AA, Wong CP, Wong SW, Mohamed Z. Seizure; 2011 Sep; 20(7):546-53. PubMed ID: 21530324 [Abstract] [Full Text] [Related]
9. Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs. Hung CC, Chen CC, Lin CJ, Liou HH. Pharmacogenet Genomics; 2008 May; 18(5):390-402. PubMed ID: 18408562 [Abstract] [Full Text] [Related]
10. Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis. Bournissen FG, Moretti ME, Juurlink DN, Koren G, Walker M, Finkelstein Y. Epilepsia; 2009 Apr; 50(4):898-903. PubMed ID: 19178561 [Abstract] [Full Text] [Related]
11. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy. Wang P, Yin T, Ma HY, Liu DQ, Sheng YH, Wang C, Zhou BT. Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491 [Abstract] [Full Text] [Related]
12. Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment. Grover S, Gourie-Devi M, Baghel R, Sharma S, Bala K, Gupta M, Narayanasamy K, Varma B, Gupta M, Kaur K, Talwar P, Kaur H, Giddaluru S, Sharma A, Brahmachari SK, Indian Genome Variation Consortium, Kukreti R. Pharmacogenomics; 2010 Jul; 11(7):927-41. PubMed ID: 20602612 [Abstract] [Full Text] [Related]
13. Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients. Mosyagin I, Runge U, Schroeder HW, Dazert E, Vogelgesang S, Siegmund W, Warzok RW, Cascorbi I. Epilepsia; 2008 Sep; 49(9):1555-61. PubMed ID: 18494787 [Abstract] [Full Text] [Related]
14. Association between lamotrigine concentrations and ABCB1 polymorphisms in patients with epilepsy. Lovrić M, Božina N, Hajnšek S, Kuzman MR, Sporiš D, Lalić Z, Božina T, Granić P. Ther Drug Monit; 2012 Oct; 34(5):518-25. PubMed ID: 22972536 [Abstract] [Full Text] [Related]
15. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs. Taur SR, Kulkarni NB, Gandhe PP, Thelma BK, Ravat SH, Gogtay NJ, Thatte UM. J Postgrad Med; 2014 Oct; 60(3):265-9. PubMed ID: 25121365 [Abstract] [Full Text] [Related]
16. The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population. Shahwan A, Murphy K, Doherty C, Cavalleri GL, Muckian C, Dicker P, McCarthy M, Kinirons P, Goldstein D, Delanty N. Epilepsy Res; 2007 Feb; 73(2):192-8. PubMed ID: 17125969 [Abstract] [Full Text] [Related]
17. Lack of association between ABCB1 gene polymorphisms and pharmacoresistant epilepsy: an analysis in a western Chinese pediatric population. Dong L, Luo R, Tong Y, Cai X, Mao M, Yu D. Brain Res; 2011 May 19; 1391():114-24. PubMed ID: 21420937 [Abstract] [Full Text] [Related]
18. Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Volk HA, Löscher W. Brain; 2005 Jun 19; 128(Pt 6):1358-68. PubMed ID: 15716304 [Abstract] [Full Text] [Related]
19. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, Wood NW, Sisodiya SM. N Engl J Med; 2003 Apr 10; 348(15):1442-8. PubMed ID: 12686700 [Abstract] [Full Text] [Related]
20. Association between ABCB1 genotype and seizure outcome in Collies with epilepsy. Muñana KR, Nettifee-Osborne JA, Bergman RL, Mealey KL. J Vet Intern Med; 2012 Apr 10; 26(6):1358-64. PubMed ID: 22998209 [Abstract] [Full Text] [Related] Page: [Next] [New Search]